Catscratch Disease Clinical Presentation

  • Author: Stephen J Nervi, MD; Chief Editor: Burke A Cunha, MD   more...
 
Updated: Nov 21, 2011
 

History

Patients with catscratch disease (CSD) most often seek medical care because of tender regional lymphadenopathy, typically involving axillary, cervical, submandibular, or preauricular nodes.

Most patients with CSD report a history of exposure to cats, and especially kittens. When questioned, patients may recall being scratched, licked, or bitten by a cat in the previous 2-8 weeks. Transmission can occur by petting alone with subsequent self-inoculation via a mucous membrane, skin break, or conjunctiva. However, infection with B henselae can be transmitted by arthropod vectors, and a history of an animal scratch or bite is not necessary for disease transmission.[35]

More than 90% of patients with CSD develop one or more 3- to 5-mm red-brown nontender papules at the site of inoculation 3-10 days after the bacteria are introduced. These primary lesions last for 1-3 weeks then recede as lymphadenopathy appears.

Within 1-3 weeks, lymphadenopathy develops in a single node or group of regional nodes draining the inoculation site. Single node involvement occurs in more than one half of patients. More than 65% of cases involve the nodes in the axillae or anterior or posterior triangles of the neck. Inguinal lymphadenopathy has been reported in 17% of cases.

Lymphadenopathy can be moderately tender, with erythema and increased warmth of the overlying skin. Lymphadenopathy remains regional and typically resolves within 2-4 months but may last up to 6-12 months. Rarely, it may persist for a year or more. Approximately 10-30% of nodes may suppurate, requiring needle aspiration.

Approximately 50% of patients also experience systemic symptoms. These might include the following (see also Table 1, below):

  • Malaise/fatigue (29.4%)
  • Fever (28%)
  • Anorexia (14.5%)
  • Headache (13%)
  • Sore throat (7%)
  • Arthralgia (2.5%)

CNS findings are present in 5% of patients with CSD. In addition to headaches, these may include mental status changes, seizures, myelitis, transient peripheral neuropathy, and retinitis. The presence of abdominal pain with a history consistent with CSD suggests CSD hepatitis/splenitis, a self-limited granulomatous condition.

Table 1. Clinical Manifestations of CSD[4] (Open Table in a new window)

Sign or SymptomPercentage, %Average Duration, d
Adenopathy10014-180
Adenopathy only5214-180
Inoculation site59-937
Fever >101°F (38.3°C)32-606
Malaise/fatigue2913
Headache134
Anorexia, weight loss, emesis145
Splenomegaly1211
Sore throat52
Rash58.5
Parotid swelling2-
Conjunctivitis4.5-

Margileth et al studied a series of 1312 patients referred for chronic lymphadenopathy. The diagnosis of CSD was confirmed in 1174 patients via catscratch antigen (CSA) testing, similar to the tuberculosis purified protein derivative (PPD) test. Of this cohort, 88% exhibited a typical course characterized by lymphadenopathy lasting an average of 3 months. Fever and malaise/fatigue were described in approximately one third of patients, none of whom was symptomatic for longer than 1 month.

An unusual presentation was experienced by 11.6% of the cohort. Of these, Parinaud oculoglandular syndrome (POS) was found in half the patients, followed in decreasing order of frequency by encephalopathy (2.3%), systemic disease (2%), erythema nodosum (0.6%), atypical pneumonia (0.2%), breast tumor (0.2%), and thrombocytopenic purpura (0.1%).

A subset of patients with severe systemic disease was observed for 7 years.

Differences between the group with severe disease and those patients with typical CSD included more frequent primary skin or mucous membrane lesions, fewer animal contacts and cat scratches, greater frequency and duration of fevers, and other constitutional symptoms.

Skin eruptions (eg, urticaria, vesiculopapular lesions, erythema nodosum) occurred 4 times more often in the severe CSD group compared with the typical CSD group. Demographics of the severe disease group included a greater percentage of adult males, who tended to have larger and multiple affected lymph nodes. Fortunately, all patients fully recovered. The longest period of recuperation was 4.5 years.

Another interesting finding from this series was evidence of recurrent CSD. Three of the patients in the severe disease category experienced recurrences at 4- to 20-month intervals. One patient presented with recurrent cervical lymphadenitis, whereas the other 2 patients experienced systemic symptoms with periodic fever, malaise, headache, and weight loss. In one patient, the episodes lasted 1-3 months, with a 20-month interval, while the second patient experienced similar episodes with a 10-month interval.

Next

Physical Examination

In 1-3 weeks, the inoculum-site lesion evolves from a small, 2- to 5-mm reddish-brown macule or vesicle to a papule or pustule (see the images below). Often, it is mistaken for an insect bite. Lesions typically are nonpruritic and heal in days to months without scarring.

Papulopustular lesions of a primary inoculation siPapulopustular lesions of a primary inoculation site on the hand of a 16-year-old patient. These lesions had been present for approximately 3 weeks. A catscratch antigen skin test was positive with 15-mm induration. No treatment was administered, and her condition resolved spontaneously in 2.5 months. Courtesy of Andrew Margileth, MD. A crusted primary inoculation papule on the neck oA crusted primary inoculation papule on the neck of a 4-year-old child. Note the adjacent lymphadenitis. This patient had contact with cats and had multiple scratches. Courtesy of Andrew Margileth, MD.

Careful examination may reveal an inoculation papule in the majority of patients. Given the tendency to hold cats against one's chest, the lesion is found most often on the head or upper extremities. Include the scalp, finger web spaces, eyelids, and conjunctiva in a thorough inspection. Multiple sites may be infected.

A transitory rash may occur early in the course of the disease. Most commonly, the rash is an evanescent maculopapular rash.

One or more nodes draining the site of inoculation enlarge approximately 2 weeks (range 5-50 d) after contact with the kitten or cat. The overlying skin may be warm and erythematous, but only rarely is an associated cellulitis present. (See the image below.)

This 10-year-old child had contact with dogs but nThis 10-year-old child had contact with dogs but not cats. The impressive lymphadenitis had been present for 5 weeks and was not tender. Pathologic examination of a biopsy specimen of the lymph node revealed nonspecific changes. She had a positive catscratch disease skin test result and negative purified protein derivative skin test results. Treatment with cephalexin was administered with a good response. Complete resolution occurred in 4.5 months. Courtesy of Andrew Margileth, MD.

The upper extremities are the most common location (46% axillary and epitrochlear nodes), followed by the neck and jaw region (26% cervical and submandibular nodes), the groin (17.5% femoral and inguinal), preauricular region (7%), and clavicular region (2%). In 10-20% of cases, more than one region is affected. Node size is typically 1-5 cm but may enlarge to 8-10 cm, or occasionally larger. Lymphadenitis resolves over 2-4 months, rarely persisting longer than a year.

Suppuration of the involved nodes occurs in 8.5-30% of patients. The risk of suppuration is proportionate to the size of the lymphadenopathy. Nodes that drain may heal with scarring.

Conjunctival CSD may manifest as nonsuppurative conjunctivitis or ocular granuloma.

Fever, if present, is typically low grade. In one series of 1200 cases of catscratch disease, only 9% of patients had a fever higher than 39°C. Fever is present in only 30-50% of patients and generally lasts for 1-7 days. About 32% of patients have prolonged fever, or one lasting up to 3 weeks. Such fever suggests progression to suppurative lymphadenitis.

CSD may present as fever of unknown origin. In a series of prolonged fever without a source, CSD was one of the most common diagnoses.[36] Adenopathy may not be present. Abdominal pain may be the initial finding, along with fever, in hepatosplenic CSD disease.

Malaise, fatigue, and other constitutional symptoms occur in up to 30% of patients. Headache, sore throat, and anorexia are noted in approximately 13% of patients.

A report from Canada describes CSD presenting as acute mastoiditis in a 6-year-old girl.[37]

Less common symptoms are splenomegaly (11%), exanthems (4.5%), conjunctivitis (4.3%), and parotid swelling (1.4%). Although erythema nodosum, erythema marginatum, erythema multiforme, and erythema annulare have been associated with CSD, exanthems consist of a truncal maculopapular rash.

Previous
Next

Atypical Catscratch Disease

Other problems (ie, atypical CSD) occur in approximately 10% of cases. Atypical manifestations of CSD include the following (see also Table 2, below):

  • Parinaud oculoglandular syndrome
  • Central nervous system (CNS) involvement
  • Hepatosplenic CSD
  • Endocarditis
  • Osteomyelitis
  • Joint pain (arthritis, synovitis)
  • Respiratory complaints (atypical pneumonitis)
  • Dermatologic manifestations

Table 2. Clinical Manifestations of Atypical CSD[14, 3] (Open Table in a new window)

Clinical Feature Margileth,



n = 1174, %



Carithers,



n = 1200, %



Typical presentation88.495
Inoculation lesion (skin, eye, mucous membrane)58.6
Unusual presentation11.65
Parinaud oculoglandular syndrome6.34
Encephalopathy2.30.25
Systemic disease, severe, chronic2
Erythema nodosum0.60.42
Atypical pneumonia0.2
Breast tumor0.2
Thrombocytopenic purpura0.10.08

Parinaud oculoglandular syndrome

Parinaud oculoglandular syndrome, which is characterized by unilateral conjunctivitis with adjacent preauricular lymphadenopathy, occurs in 2-3% of patients with CSD.[38] In these patients, the site of inoculation is usually the eyelid or conjunctiva secondary to a lick, scratch, or bite.

Subsequent rubbing of the eye often leads to spreading. After a few weeks, the patient develops nonpurulent conjunctivitis, an ocular granuloma, or both. Preauricular adenopathy also develops. Physical findings involving the eye resolve in a few months without residual damage.

Examination of the palpebral conjunctiva on the involved side reveals either a characteristic granulomatous lesion 2-4 mm in diameter or a frank scratch. While POS has been associated with other infections (eg, tuberculosis, tularemia, lymphogranuloma venereum), it most commonly is associated with CSD. Prognosis is identical to that of typical CSD.

Central nervous system involvement

CNS findings occur in 5% of patients with CSD and include encephalitis, seizures, myelitis, peripheral neuropathy, and neuroretinitis.

Encephalopathy is a complication of CSD described in up to 5% of patients Although encephalitis usually follows development of lymphadenopathy by 1-6 weeks, it may precede or occur without the presence of lymph node involvement.[39, 40, 41, 42] Most patients are young, in parallel to the spectrum of patients diagnosed with CSD.

Encephalitis occurs in approximately 2-4% of CSD cases; the condition is characterized by confusion, restlessness, combativeness, and disorientation. Generalized headache and transient nuchal rigidity are often present. Symptoms rapidly progress within hours to seizures and coma.[43] Seizures occur in one half to three fourths of patients and may be self-limited or progress to status epilepticus. Coma complicated by respiratory depression requiring intubation and ventilatory assistance often is reported.

Laboratory findings from examination of cerebrospinal fluid (CSF) often are normal. Even when CSF results are abnormal, no consistent patterns emerge. Abnormal findings from EEG, when observed, are nonspecific and transient. CT or MRI study findings of the brain are usually normal or reveal transient abnormalities.

CSD encephalitis is self-limited, does not mandate specific treatment, and rarely results in persistent impairment. Recovery is usually complete in 2-10 days, with no sequelae. However, persistent cognitive impairment and death have been reported in some cases.

Transverse myelitis presenting as Brown-Sequard syndrome has occurred in a 44-year-old man.[44] Myelitis presented with extremity weakness, abnormal reflexes, sensory loss, and sphincter dysfunction. The patient experienced rapid resolution of symptoms in a few days and was asymptomatic within 3 months.

Cranial or peripheral nerve involvement may occur. Two children with oculoglandular CSD were reported to have developed transient facial nerve paresis. Three adult women reportedly developed peripheral neuritis lasting 1-4 months associated with the onset of lymphadenitis due to CSD.

Acute onset, self-resolving, recurrent expressive aphasia has been reported.

Neuroretinitis (Leber stellate neuroretinitis, Leber idiopathic stellate retinopathy,[45] Leber idiopathic stellate maculopathy) was first described in 1916. It often follows lymphadenopathy or an influenzalike syndrome. Patients present with painless, unilateral (rarely bilateral) decreased vision associated with central scotomata. Funduscopic examination reveals papilledema with macular exudates in a star pattern.

Permanent loss of vision is not reported, although recovery may take 1-3 months. CSD neuroretinitis should be followed by an ophthalmologist but is predictably self-limited.

Recovery from CNS manifestations of CSD may be slow. Some individuals require one year or longer to recover from CNS manifestations.

Hepatosplenic catscratch disease

Hepatosplenic CSD is a rare form of atypical CSD found in patients who are immunocompetent. Individuals present with daily fevers up to 104°F (40°C) and no identifiable cause.

Physical examination findings are usually normal, with occasional detection of well-healed cutaneous scars secondary to cat scratches. Abdominal discomfort, without focal findings, is commonly reported. Lymphadenopathy is present in approximately half the cases. Hepatosplenomegaly, jaundice, and elevated transaminase levels are not associated with this condition.

The diagnosis is based on characteristic filling defects in the liver, spleen, or both as detected by ultrasonography, CT scanning, and a positive B henselae titer. The liver is described as having a nutmeg appearance with stellate necrotizing granulomata on the histologic examination.

Intravenous administration of aminoglycoside antibiotics has been reported to be helpful. Most patients become afebrile within 48 hours of initiating treatment; however, in a few cases, fever has persisted for up to a month, even with antibiotic therapy.

Endocarditis

Bartonella species account for approximately 3% of all cases of endocarditis. Currently, many cases of blood culture–negative endocarditis are believed to be the result of infection with Bartonella species. Bartonella endocarditis should be considered in patients with manifestations of endocarditis and negative blood culture results who have regular contact with cats.[46] Possible risk factors include alcoholism, homelessness, and body louse infestation.

Some cases diagnosed as Chlamydia endocarditis also are likely to be caused by Bartonella species because of the high prevalence of cross-reacting antibodies.

Patients with Bartonella endocarditis often require valve replacement.

Musculoskeletal involvement

Osteomyelitis secondary to B henselae, while still rare, is being reported with increased frequency. Hajjaji et al reviewed the literature and found 47 cases that met criteria and had sufficient data.[47] They noted the vertebral column and pelvic girdle were the most commonly affected locations.

MRI, scintigraphy, and CT scanning can all be used to demonstrate bone involvement. Immunosuppression was not a risk factor. Affected patients responded well to therapy without significant long-term effects. In a case report, a child with osteomyelitis and epidural extension confirmed by polymerase chain reaction responded to intravenous clindamycin and gentamicin.[48]

A few patients with CSD have been described with osteolytic lesions but not true osteomyelitis. These patients do not have a fever or leukocytosis.

Back pain as the presenting symptom has been reported. In one case report, CT scanning revealed a soft-tissue mass dorsal to the processi transversa L1-2, and MRI revealed a contrast-enhancing paraspinal mass with infiltration of the erector spinae consistent with inflammation.[49] B henselae immunoglobulin (Ig)M antibody findings were positive. The patient spontaneously recovered after about 1 month.

Dermatologic manifestations

Other dermatologic manifestations occur in approximately 5% of patients and are more likely to occur in patients with more severe or atypical disease. These manifestations include macular, maculopapular, morbilliform, and petechial rashes. They typically are nonpruritic and resolve in days to weeks. Cases of erythema multiforme, erythema nodosum, erythema annulare, and ecchymoses associated with thrombocytopenia have been reported in patients with CSD, but these are rare.

Characterized by painful, tender, subcutaneous nodules on the skin, erythema nodosum may present 1-6 weeks after onset of adenopathy in less than 1% of patients with CSD. These nodules resolve without sequelae.

Thrombocytopenia purpura is quite rare and is usually transient.

Previous
Next

Immuocompromised Patients

Patients with HIV infection have an increased risk of CSD. The inoculation sites may be difficult to distinguish from Kaposi sarcoma. The normally benign disease of CSD can be life-threatening to an immunocompromised host. These patients, as well as other immunocompromised patients (eg, those with cancer, persons who have undergone transplantation) may develop bacillary angiomatosis, bacillary peliosis, or persistent or relapsing fever with bacteremia.

Bacillary angiomatosis is a vasculoproliferative disease that mostly involves the skin but can involve other organs. It manifests as numerous brown to violaceous tumors of the skin and subcutaneous tissues. Without antibiotic therapy, the disease progresses with dissemination. The lesions are very similar to verruga peruana, the chronic form of Carrión disease (Oroya fever) from Bartonella bacilliformis infection.

Bacillary peliosis involves the solid internal organs with reticuloendothelial elements (usually the liver, but the spleen, abdominal lymph nodes, and bone marrow may also be involved). Vasculoproliferation of sinusoidal hepatic capillaries may result in blood-filled spaces in the liver.

Previous
 
 
Contributor Information and Disclosures
Author

Stephen J Nervi, MD  Staff Physician, Department of Dermatology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Stephen J Nervi, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Sigma Xi

Disclosure: Nothing to disclose.

Coauthor(s)

Rose A Ressner, DO  Staff, Department of Infectious Diseases, Walter Reed Army Medical Center

Rose A Ressner, DO is a member of the following medical societies: American College of Physicians-American Society of Internal Medicine, Armed Forces Infectious Diseases Society, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Joyce R Drayton, MD  Assistant Professor, Department of Internal Medicine, Division of Infectious Disease, Morehouse School of Medicine

Joyce R Drayton, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American College of Preventive Medicine, American Holistic Medical Association, Infectious Diseases Society of America, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Rajendra Kapila, MD, MBBS  Associate Professor, Department of Medicine, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Rajendra Kapila, MD, MBBS is a member of the following medical societies: American College of Physicians, American Medical Association, Infectious Diseases Society of America, and Infectious Diseases Society of New Jersey

Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD  Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Additional Contributors

Jeffrey Glenn Bowman, MD, MS Consulting Staff, Highfield MRI

Disclosure: Nothing to disclose.

Itzhak Brook, MD, MSc Professor, Department of Pediatrics, Georgetown University School of Medicine

Itzhak Brook, MD, MSc is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, Armed Forces Infectious Diseases Society, Association of Military Surgeons of the US, Infectious Diseases Society of America, International Immunocompromised Host Society, International Society for Infectious Diseases,Medical Society of the District of Columbia, New York Academy of Sciences, Pediatric Infectious Diseases Society, Society for Ear, Nose and Throat Advances in Children, Society for Experimental Biology and Medicine, Society for Pediatric Research, Southern Medical Association, and Surgical Infection Society

Disclosure: Nothing to disclose.

Jack A Coleman, MD Consulting Staff, Franklin Surgical Associates

Jack A Coleman, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Sleep Medicine, American Bronchoesophagological Association, American College of Surgeons, American Laryngological Rhinological and Otological Society, American Society for Laser Medicine and Surgery, and Association of Military Surgeons of the US

Disclosure: Accarent, Inc. Honoraria Speaking and teaching

Joseph Domachowske, MD Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York Upstate Medical University

Joseph Domachowske, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Dirk M Elston, MD Director, Ackerman Academy of Dermatopathology, New York

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Allan D Friedman, MD, MPH Chairman, Division of General Pediatrics, VCUH Health System; Professor of Pediatrics, Virginia Commonwealth University

Allan D Friedman, MD, MPH is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Lynn L Horvath, MD Clinical Assistant Professor of Medicine/Infectious Disease, University of Texas Health Science Center; Consulting Staff, Department of Infectious Disease, Brooke Army Medical Center

Lynn L Horvath, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians-American Society of Internal Medicine, American Society for Microbiology, Armed Forces Infectious Diseases Society, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Robert M Kellman, MD Professor and Chair, Department of Otolaryngology and Communication Sciences, State University of New York Upstate Medical University

Robert M Kellman, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Neurotology Society, American Rhinologic Society, American Society for Head and Neck Surgery, Medical Society of the State of New York, and Triological Society

Disclosure: GE Healthcare Honoraria Review panel membership; Revent Medical Honoraria Review panel membership

John W King, MD Professor of Medicine, Chief, Section of Infectious Diseases, Director, Viral Therapeutics Clinics for Hepatitis, Louisiana State University Health Sciences Center; Consultant in Infectious Diseases, Overton Brooks Veterans Affairs Medical Center

John W King, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Federation for Medical Research, American Society for Microbiology, Association of Subspecialty Professors, Infectious Diseases Society of America, and Sigma Xi

Disclosure: emedicine $50.00 Author of chapter; MERCK None Other

Carrie L Kovarik, MD Assistant Professor of Dermatology, Dermatopathology, and Infectious Diseases, University of Pennsylvania School of Medicine

Carrie L Kovarik, MD is a member of the following medical societies: Alpha Omega Alpha

Disclosure: Nothing to disclose.

John M Leedom, MD Professor Emeritus of Medicine, Keck School of Medicine of the University of Southern California

John M Leedom, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians-American Society of Internal Medicine, American Society for Microbiology, Infectious Diseases Society of America, International AIDS Society, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Kim Lundstrom, MD Consulting Staff, Department of Otolaryngology-Head and Neck Surgery, Longmont Clinic

Kim Lundstrom, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery and American Medical Association

Disclosure: Nothing to disclose.

Gauri Mankekar, MBBS, MS, DNB, PhD Consultant Otorhinolaryngologist, Department of Otolaryngology, PD Hinduja National Hospital, India

Gauri Mankekar, MBBS, MS, DNB, PhD is a member of the following medical societies: Association of Medical Consultants of Mumbai, Association of Otolaryngologists of India, and Cochlear Implant Group of India

Disclosure: Nothing to disclose.

Jill McKenzie, MD Resident, Division of Dermatology, University of Washington School of Medicine

Jill McKenzie, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, and American Medical Association

Disclosure: Nothing to disclose.

Arlen D Meyers, MD, MBA Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society

Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation Unrestricted gift Unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo Consulting; Medvoy Ownership interest Management position; Cerescan Imaging Honoraria Consulting; GYRUS ACMI Honoraria Consulting

Van Perry, MD Assistant Professor, Department of Medicine, Division of Dermatology, University of Texas School of Medicine at San Antonio

Van Perry, MD is a member of the following medical societies: American Academy of Dermatology and American Society for Laser Medicine and Surgery

Disclosure: Nothing to disclose.

Gregory J Raugi, MD, PhD Professor, Department of Internal Medicine, Division of Dermatology, University of Washington at Seattle School of Medicine; Chief, Dermatology Section, Primary and Specialty Care Service, Veterans Administration Medical Center of Seattle

Gregory J Raugi, MD, PhD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Erik D Schraga, MD Staff Physician, Department of Emergency Medicine, Mills-Peninsula Emergency Medical Associates

Disclosure: Nothing to disclose.

Barry J Sheridan, DO Chief Warrior in Transition Services, Brooke Army Medical Center

Barry J Sheridan, DO is a member of the following medical societies: American Academy of Emergency Medicine

Disclosure: Nothing to disclose.

Kerrie J Spoonemore, MD, PharmD Clinical Instructor, Department of Dermatology, University of Washington

Kerrie J Spoonemore, MD, PharmD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Russell W Steele, MD Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Michael J Wells, MD Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine

Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association

Disclosure: Nothing to disclose.

References
  1. Bergman AM, Groothedde J-W, Schellekens JFP et al. Etiology of catscratch disease: a comparison of polymerase chain reaction detection of Bartonella and Afipia felis DNA with serology and skin tests. J Infect Dis. 1995;171:916-923.

  2. Regnery R, Tappero J. Unraveling mysteries associated with cat-scratch disease, bacillary angiomatosis, and related syndromes. Emerg Infect Dis. Jan-Mar 1995;1(1):16-21. [Medline]. [Full Text].

  3. Carithers HA. Cat-scratch disease. An overview based on a study of 1,200 patients. Am J Dis Child. Nov 1985;139(11):1124-33. [Medline].

  4. Moriarty RA, Margileth AM. Cat scratch disease. Infect Dis Clin North Am. Sep 1987;1(3):575-90. [Medline].

  5. Abbasi S, Chesney PJ. Pulmonary manifestations of cat-scratch disease; a case report and review of the literature. Pediatr Infect Dis J. Jun 1995;14(6):547-8. [Medline].

  6. Chrousos GA, Drack AV, Young M, Kattah J, Sirdofsky M. Neuroretinitis in cat scratch disease. J Clin Neuroophthalmol. Jun 1990;10(2):92-4. [Medline].

  7. de Kort JG, Robben SG, Schrander JJ, van Rhijn LW. Multifocal osteomyelitis in a child: a rare manifestation of cat scratch disease: A case report and systematic review of the literature. J Pediatr Orthop B. Jul 2006;15(4):285-8.

  8. Giladi M,Champion I, Haake DA et al. Use of the blue hallo assay in the identification of genes encoding exported proteins with cleavable signal peptides:cloning of Borrelia burgdorferi plasmid gene with a signal peptide. J Bacteriol. 1993;175:4129-4136.

  9. Marra CM. Neurologic complications of Bartonella henselae infection. Curr Opin Neurol. Jun 1995;8(3):164-9. [Medline].

  10. Walvogel K, Regnery RL, Anderson BE et al. Disseminated catscratch disease: detection of R.henselae in affected tissue. Eur. J. Pediatr. 1994;153:23-27.

  11. Rolain JM, Lepidi H, Zanaret M et al. Lymph node biopsy specimens and diagnosis of catscratch disease: discussion. Emerg Infect Dis. Sep 2006;12(9):1338 -44.

  12. Avidor B, Kletter Y, Abulafia S, Golan Y, Ephros M, Giladi M. Molecular diagnosis of cat scratch disease: a two-step approach. J Clin Microbiol. Aug 1997;35(8):1924-30. [Medline]. [Full Text].

  13. Carithers HA. Cat-scratch disease; notes on its history. Am J Dis Child. Mar 1970;119(3):200-3. [Medline].

  14. Margileth AM. The diagnostic challenge of cat scratch disease. Infect Med. 1987;57-75.

  15. Parinaud H. Conjonctivite infectieuse transmise par les animaux. Ann Oculistique. 1889;101:252-253.

  16. Debre R, Lamy M, Jammet ML. La maladie des griffes de chat. Semin Hop Paris. 1950;26:1895-901.

  17. GREER WE, KEEFER CS. Cat-scratch fever; a disease entity. N Engl J Med. Apr 12 1951;244(15):545-8. [Medline].

  18. Wear DJ, Margileth AM, Hadfield TL, Fischer GW, Schlagel CJ, King FM. Cat scratch disease: a bacterial infection. Science. Sep 30 1983;221(4618):1403-5. [Medline].

  19. Margileth AW, Wear DJ, Hadfield TL, Schlagel CJ, Spigel GT, Muhlbauer JE. Cat-scratch disease. Bacteria in skin at the primary inoculation site. JAMA. Aug 17 1984;252(7):928-31. [Medline].

  20. English CK, Wear DJ, Margileth AM, Lissner CR, Walsh GP. Cat-scratch disease. Isolation and culture of the bacterial agent. JAMA. Mar 4 1988;259(9):1347-52. [Medline].

  21. Alkan S, Morgan MB, Sandin RL, Moscinski LC, Ross CW. Dual role for Afipia felis and Rochalimaea henselae in cat-scratch disease. Lancet. Feb 11 1995;345(8946):385. [Medline].

  22. Dolan MJ, Wong MT, Regnery RL, Jorgensen JH, Garcia M, Peters J, et al. Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease. Ann Intern Med. Mar 1 1993;118(5):331-6. [Medline].

  23. Zangwill KM, Hamilton DH, Perkins BA, Regnery RL, Plikaytis BD, Hadler JL, et al. Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test. N Engl J Med. Jul 1 1993;329(1):8-13. [Medline].

  24. Rolain JM, Chanet V, Laurichesse H, Lepidi H, Beytout J, Raoult D. Cat scratch disease with lymphadenitis, vertebral osteomyelitis, and spleen abscesses. Ann N Y Acad Sci. Jun 2003;990:397-403. [Medline].

  25. Da Silva K, Chussid S. Cat scratch disease: clinical considerations for the pediatric dentist. Pediatr Dent. Jan-Feb 2009;31(1):58-62. [Medline].

  26. Chen TC, Lin WR, Lu PL, Lin CY, Chen YH. Cat scratch disease from a domestic dog. J Formos Med Assoc. Feb 2007;106(2 Suppl):S65-68. [Medline].

  27. Chomel BB, Kasten RW. Bartonellosis, an increasingly recognized zoonosis. J Appl Microbiol. Sep 2010;109(3):743-50. [Medline].

  28. Lin JW, Chen CM, Chang CC. Unknown fever and back pain caused by Bartonella henselae in a veterinarian after a needle puncture: a case report and literature review. Vector Borne Zoonotic Dis. May 2011;11(5):589-91. [Medline].

  29. Jackson LA, Perkins BA, Wenger JD. Cat scratch disease in the United States: an analysis of three national databases. Am J Public Health. Dec 1993;83(12):1707-11. [Medline]. [Full Text].

  30. Reynolds MG, Holman RC, Curns AT, O'Reilly M, McQuiston JH, Steiner CA. Epidemiology of cat-scratch disease hospitalizations among children in the United States. Pediatr Infect Dis J. Aug 2005;24(8):700-4. [Medline].

  31. Sanguinetti-Morelli D, Angelakis E, Richet H, Davoust B, Rolain JM, Raoult D. Seasonality of cat-scratch disease, France, 1999-2009. Emerg Infect Dis. Apr 2011;17(4):705-7. [Medline].

  32. Ridder GJ, Boedeker CC, Technau-Ihling K, Grunow R, Sander A. Role of cat-scratch disease in lymphadenopathy in the head and neck. Clin Infect Dis. Sep 15 2002;35(6):643-9. [Medline].

  33. Fouch B, Coventry S. A case of fatal disseminated Bartonella henselae infection (cat-scratch disease) with encephalitis. Arch Pathol Lab Med. Oct 2007;131(10):1591-4. [Medline].

  34. Gerber JE, Johnson JE, Scott MA, Madhusudhan KT. Fatal meningitis and encephalitis due to Bartonella henselae bacteria. J Forensic Sci. May 2002;47(3):640-4. [Medline].

  35. Mosbacher ME, Klotz S, Klotz J, Pinnas JL. Bartonella henselae and the potential for arthropod vector-borne transmission. Vector Borne Zoonotic Dis. May 2011;11(5):471-7. [Medline].

  36. Malatack JJ, Jaffe R. Granulomatous hepatitis in three children due to cat-scratch disease without peripheral adenopathy. An unrecognized cause of fever of unknown origin. Am J Dis Child. Sep 1993;147(9):949-53. [Medline].

  37. Cheung VW, Moxham JP. Cat scratch disease presenting as acute mastoiditis. Laryngoscope. 2010;120 Suppl 4:S222. [Medline].

  38. Florin TA, Zaoutis TE, Zaoutis LB. Beyond cat scratch disease: widening spectrum of Bartonella henselae infection. Pediatrics. May 2008;121(5):e1413-25. [Medline].

  39. Carithers HA, Margileth AM. Cat-scratch disease. Acute encephalopathy and other neurologic manifestations. Am J Dis Child. Jan 1991;145(1):98-101. [Medline].

  40. Centers for Disease Control and Prevention. Encephalitis associated with cat scratch disease--Broward and Palm Beach Counties, Florida, 1994. MMWR Morb Mortal Wkly Rep. Dec 16 1994;43(49):909, 915-6. [Medline].

  41. Pampe D, Holt RM. Cat scratch disease with reversible encephalopathy. Tex Med. Feb 1984;80(2):38-9. [Medline].

  42. Pollen RH. Cat-scratch encephalitis. Neurology. Oct 1968;18(10):1031-3. [Medline].

  43. Cherinet Y, Tomlinson R. Cat scratch disease presenting as acute encephalopathy. Emerg Med J. Oct 2008;25(10):703-4. [Medline].

  44. Pickerill RG, Milder JE. Transverse myelitis associated with cat-scratch disease in an adult. JAMA. Dec 18 1981;246(24):2840-1. [Medline].

  45. François J, Verriest G, De Laey JJ. Leber's idiopathic stellate retinopathy. Am J Ophthalmol. Aug 1969;68(2):340-5. [Medline].

  46. Raoult D, Fournier PE, Drancourt M, Marrie TJ, Etienne J, Cosserat J, et al. Diagnosis of 22 new cases of Bartonella endocarditis. Ann Intern Med. Oct 15 1996;125(8):646-52. [Medline].

  47. Hajjaji N, Hocqueloux L, Kerdraon R, Bret L. Bone infection in cat-scratch disease: a review of the literature. J Infect. May 2007;54(5):417-21. [Medline].

  48. Mirakhur B, Shah SS, Ratner AJ, Goldstein SM, Bell LM, Kim JO. Cat scratch disease presenting as orbital abscess and osteomyelitis. J Clin Microbiol. Aug 2003;41(8):3991-3. [Medline]. [Full Text].

  49. ten Hove CH, Gubler FM, Kiezebrink-Lindenhovius HH. Back pain in a child caused by cat scratch disease. Pediatr Infect Dis J. Mar 2009;28(3):258. [Medline].

  50. Vermeulen MJ, Verbakel H, Notermans DW, Reimerink JH, Peeters MF. Evaluation of sensitivity, specificity and cross-reactivity in Bartonella henselae serology. J Med Microbiol. Mar 2010;(Epub ahead of print).;59:743-5. [Medline].

  51. Huang J, Dai L, Lei S, et al. [Application of Warthin-Starry stain, immunohistochemistry and transmission electron microscopy in diagnosis of cat scratch disease]. Zhonghua Bing Li Xue Za Zhi. Apr 2010;39(4):225-9. [Medline].

  52. Wang CW, Chang WC, Chao TK, Liu CC, Huang GS. Computed tomography and magnetic resonance imaging of cat-scratch disease: a report of two cases. Clin Imaging. Jul-Aug 2009;33(4):318-21. [Medline].

  53. Min KW, Reed JA, Welch DF et al. Morphologically variable bacilli of catscratch disease identified by immunocytochemical labeling with antibodies to Rochalimaea Henselae. Am. J. Clin. Pathol. 1994;101:607-610.

  54. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. Nov 15 2005;41(10):1373-406. [Medline].

  55. Dharnidharka VR, Richard GA, Neiberger RE, Fennell RS 3rd. Cat scratch disease and acute rejection after pediatric renal transplantation. Pediatr Transplant. Aug 2002;6(4):327-31. [Medline].

  56. Bass JW, Freitas BC, Freitas AD, Sisler CL, Chan DS, Vincent JM, et al. Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr Infect Dis J. Jun 1998;17(6):447-52. [Medline].

  57. Margileth AM. Antibiotic therapy for cat-scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature. Pediatr Infect Dis J. Jun 1992;11(6):474-8. [Medline].

  58. Musso D, Drancourt M, Raoult D. Lack of bactericidal effect of antibiotics except aminoglycosides on Bartonella (Rochalimaea) henselae. J Antimicrob Chemother. Jul 1995;36(1):101-8. [Medline].

  59. Ives TJ, Manzewitsch P, Regnery RL, Butts JD, Kebede M. In vitro susceptibilities of Bartonella henselae, B. quintana, B. elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to macrolide antibiotics as determined by immunofluorescent-antibody analysis of infected Vero cell monolayers. Antimicrob Agents Chemother. Mar 1997;41(3):578-82. [Medline]. [Full Text].

  60. Holley HP Jr. Successful treatment of cat-scratch disease with ciprofloxacin. JAMA. Mar 27 1991;265(12):1563-5. [Medline].

  61. Bogue CW, Wise JD, Gray GF, Edwards KM. Antibiotic therapy for cat-scratch disease?. JAMA. Aug 11 1989;262(6):813-6. [Medline].

  62. Koehler JE, LeBoit PE, Egbert BM, Berger TG. Cutaneous vascular lesions and disseminated cat-scratch disease in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Ann Intern Med. Sep 15 1988;109(6):449-55. [Medline].

  63. Koehler JE, Sanchez MA, Garrido CS, Whitfeld MJ, Chen FM, Berger TG, et al. Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis. N Engl J Med. Dec 25 1997;337(26):1876-83. [Medline].

Previous
Next
 
Papulopustular lesions of a primary inoculation site on the hand of a 16-year-old patient. These lesions had been present for approximately 3 weeks. A catscratch antigen skin test was positive with 15-mm induration. No treatment was administered, and her condition resolved spontaneously in 2.5 months. Courtesy of Andrew Margileth, MD.
A crusted primary inoculation papule on the neck of a 4-year-old child. Note the adjacent lymphadenitis. This patient had contact with cats and had multiple scratches. Courtesy of Andrew Margileth, MD.
This 13-year-old girl developed fatigue and malaise after being licked and scratched by a cat. The typical conjunctival granuloma was accompanied by a parotid mass and intraparotid adenitis. No treatment was administered, and all her signs and symptoms resolved in 3 months. Courtesy of Andrew Margileth, MD.
This 9-year-old boy developed catscratch disease (CSD) encephalitis and a papular pruritic dermatitis after sustaining cat scratches and developing regional lymphadenitis. He was in a coma for 4 days but experienced a complete and rapid recovery within 3 weeks. Biopsy of the skin rash revealed nonspecific changes. The CSD antigen skin test result was positive. Courtesy of Andrew Margileth, MD.
This 2.5-year-old boy was recovering from catscratch disease acquired 10 months before when he developed this neck abscess over a period of 3 weeks. Biopsy revealed caseating granulomas; acid-fast bacillus and Warthin-Starry stain results were negative. Courtesy of Andrew Margileth, MD.
This 10-year-old child had contact with dogs but not cats. The impressive lymphadenitis had been present for 5 weeks and was not tender. Pathologic examination of a biopsy specimen of the lymph node revealed nonspecific changes. She had a positive catscratch disease skin test result and negative purified protein derivative skin test results. Treatment with cephalexin was administered with a good response. Complete resolution occurred in 4.5 months. Courtesy of Andrew Margileth, MD.
Warthin-Starry stained sections of lymph node showing chains and clusters of organisms. Courtesy of Andrew Margileth, MD.
Table 1. Clinical Manifestations of CSD[4]
Sign or SymptomPercentage, %Average Duration, d
Adenopathy10014-180
Adenopathy only5214-180
Inoculation site59-937
Fever >101°F (38.3°C)32-606
Malaise/fatigue2913
Headache134
Anorexia, weight loss, emesis145
Splenomegaly1211
Sore throat52
Rash58.5
Parotid swelling2-
Conjunctivitis4.5-
Table 2. Clinical Manifestations of Atypical CSD[14, 3]
Clinical Feature Margileth,



n = 1174, %



Carithers,



n = 1200, %



Typical presentation88.495
Inoculation lesion (skin, eye, mucous membrane)58.6
Unusual presentation11.65
Parinaud oculoglandular syndrome6.34
Encephalopathy2.30.25
Systemic disease, severe, chronic2
Erythema nodosum0.60.42
Atypical pneumonia0.2
Breast tumor0.2
Thrombocytopenic purpura0.10.08
Table 3. Response to Medications
Ciprofloxacin



500 PO bid



Case Report



5 adults



"Dramatic improvement" in a few days; defined as resolution of symptoms (ie, malaise and pain)Holley[60]
Gentamicin



5 mg/kg/d IV/IM



Case Report



3 febrile children; 2 with hepatitis, 1 with painful regional lymphadenopathy



Resolution of fever and systemic symptoms in 1-2 daysBogue et al[61]
TMP-SMZ



6-8 mg TMP/kg/d PO



Uncontrolled retrospective study



60 patients with prolonged fever and systemic symptoms



58% effective, 7-day course (see above)Margileth[41]
Rifampin 10-20 mg/kg/d PO/IVUncontrolled retrospective study



60 patients with prolonged fever and systemic symptoms



87% effective, 7- to 14-day course (see above)Margileth[57]
Azithromycin



500 mg PO qd for 1 day, then 250 mg PO qd for 4 days



Prospective placebo-controlled, double-blind study



29 patients



80% of lymph node volume (as measured by ultrasonography) resolved in 30 days in 7 of 15 patients on azithromycin vs 1 of 15 control patients Bass et al[56]
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.